Funds and ETFs McKesson Corporation

Equities

MCK

US58155Q1031

Pharmaceuticals

Market Closed - Nyse 04:00:02 2024-05-24 pm EDT 5-day change 1st Jan Change
560.7 USD +0.48% Intraday chart for McKesson Corporation -0.67% +21.11%

ETFs positioned on McKesson Corporation

Name Weight AuM 1st Jan change Investor Rating
0.18% 7 M€ +5.52% -
0.18% 32 M€ +0.84% -
0.18% 17 M€ +5.53% -
0.18% 50 M€ +11.32%
0.17% 6 M€ +17.98% -
0.17% 121 M€ +8.46% -
0.15% 34 M€ +12.43% -
0.15% 1 M€ -.--%
0.14% 57 M€ +22.25% -
0.13% 786 M€ -.--%
0.13% 23 M€ -.--% -
0.12% 206 M€ -.--%
0.11% 2,517 M€ +13.18% -
0.11% 14 M€ +16.19% -
0.10% 283 M€ +21.92%
0.10% 9 M€ +10.11% -
0.10% 1,166 M€ +0.26% -
0.10% 607 M€ +0.05% -
0.10% 0 M€ 0.00% -
0.09% 571 M€ +8.06% -
0.08% 391 M€ +9.26% -
0.08% 34 M€ +9.10% -
McKesson Corporation specializes in pharmaceutical product distribution. The group also offers technological services to healthcare companies. Net sales break down by activity as follows: - distribution of pharmaceutical products (87%); - distribution of medical and surgical products (4%); - other (1.6%): primarily technology services and software sales. The remaining net sales (7.4%) are from international activities.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
18
Last Close Price
560.7 USD
Average target price
584.1 USD
Spread / Average Target
+4.16%
Consensus
  1. Stock Market
  2. Equities
  3. MCK Stock
  4. Funds and ETFs McKesson Corporation